Daily equity-report by epic research 25 feb 2013


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Daily equity-report by epic research 25 feb 2013

  1. 1. HEADLINES -=6  Indian Market  Indian equity markets were down 0.03%  Nifty down by 1.95 pts and settle at 5850.30  Sensex down by 8.35 pts at 19317.01  Bank Nifty up by 19.60 pts at 12100.50  Global Market DAILY EQUITY  European markets were up with FTSE NEWSLETTER up by 48.51 closed at 6340 ,CAC up by 46.81 closed at 3671 and DAX up by 25TH FEBRUARY 2013 41.73 closed at 7625.  Dow future was up 34.00 closed at 13906.00  HEADLINES• RBI officials fear Budget choices give less room for rate cuts• Jet Airways falls 5% on concerns over Etihad deal• SME: Channel Nine Entertainment IPO opens for subscription• Ex-Infosys executive aims to shake up IT industry billing model WWW.EPICRESEARCH.CO 09752199966
  2. 2.  MARKET ANALYSIS:  Key benchmark indices reversed intraday gains and slipped into the red in late trade as index heavyweight ITC dropped and as another index heavyweight Reliance Industries (RIL) trimmed intraday gains. The market breadth, indicating the overall health of the market, turned negative from positive in late trade, having alternately moved between positive and negative zone throughout the trading session.  BSE Sensex was down 16.20 points or 0.08% to 19,309.16.  CNX Nifty was down 3.90 points or 0.07% to 5,848.35.  Among the 30-share Sensex pack, 16 stocks gained while the rest of them declined.  Sun Pharmaceutical Industries rose 2.04% to Rs 811.90 after striking a record high of Rs 814.20 in intraday trade today, 22 February 2012. State run National Thermal Power Corporation (NTPC) rose 0.16%. NTPC has tied up a term loan facility of $250 million with State Bank of India, New York Branch and Mizuho Corporate Bank, Singapore Branch as Arrangers and Lenders. The loan agreement signed in New York by Mr. A.K. Singhal, Director (Finance), empowers NTPC for utilization of the proceeds of the loan towards capital expenditure for procurement of goods and services for the ongoing and new projects and renovation and modernization of power generation stations of the company. Bhel took over BHPV as its 100% subsidiary in 2008. However, the companys performance was not upto the mark, as it remained a separate company and it could not derive full benefits of synergy with Bhel. STOCKS TO WATCH  FII’s and DII’s  ANDHRA BANKCATEGORY DATE BUY SELL NET  AUROBINDO PHARMA FII 22-Feb-13 2864.02 2583.72 280.3  AMBUJA  BHARTI AIRTEL DII 22-Feb-13 937.21 1289.19 -351.98 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  HDILPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4  PUNJLYODNIFTY 6103 6026 5949 5900 5872 5823 5795 5718 5641  SUZLON  RENUKA  WELCORP WWW.EPICRESEARCH.CO 09752199966
  3. 3. .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks ConsolidateSCRIPS RATE VOL. PR. NET %  Strategy: Sell on rise (000) CLOSE CHAN CHANG GE E  Support: 5800 Bharti  Resistance: 5900 309.65 6409.00 296.20 13.45 4.54 Airtel BANK NIFTY DLF 281.45 13577.50 272.45 9.00 3.30  Bank Nifty looks Consolidate Wipro 415.95 2171.76 405.80 10.15 2.50  Strategy: Sell on rise Power 109.05 7905.51 106.85 2.20 2.06  Support: 12040 Grid Sun  Resistance: 12170 811.55 1284.90 797.50 14.05 1.76Pharma 460  PREVIOUS PERFORMANCE .0 DAILY NIFTY LOOSERS TYPE SCRIP B/S RESULTSCRIPS RATE VOL. PR. NET % (000) CLOSE CHAN CHAN ADANI NOT CASH S POWER EXECUTED GE GE CASH SESA GOA S SL TRIGERREDHindustan 455.40 2420.05 468.25 -12.85 -2.74Unilever FUTURE PUNJ LLYOD S SL TRIGERRED Coal 331.70 2323.29 340.30 -8.60 -2.53 India RELIANCE JP FUTURE S SL TRIGERRED 70.25 35866.74 71.80 -1.55 -2.16 POWERAssociate Maruti 1438.40 648.68 1467.50 -29.10 -1.98 Suzuki HDFC 799.85 2776.08 815.05 -15.20 -1.86 UPCOMING RESULTS  PANTALOON  DHANUSH TECH WWW.EPICRESEARCH.CO 09752199966
  4. 4. MARKET CALLS CASH SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS ANDHRA BANK SELL 99.30 98.80 98.00 99.80 BHARTI AIRTEL BUY 309.90 311.90 314.90 307.90 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. AUROBINDO SELL 180.35 179.35 177.85 181.35 PHARMA AMBUJA BUY 198.90 199.90 200.90 197.90 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.